FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

21874811000001107: Targaxan 550mg tablets (Norgine Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 06-Mar 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
72612901000001116 Targaxan 550mg tablets (Norgine Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
72613001000001113 Targaxan 550mg tablets (Norgine Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Targaxan 550mg tablets (Norgine Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Targaxan 550mg tablets (Norgine Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Targaxan 550mg tablets (Norgine Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Targaxan 550mg tablets (Norgine Pharmaceuticals Ltd) Is a Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Targaxan 550mg tablets (Norgine Pharmaceuticals Ltd) Has active ingredient Rifaximin false Inferred relationship Existential restriction modifier
Targaxan 550mg tablets (Norgine Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Targaxan 550mg tablets (Norgine Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Targaxan 550mg tablets (Norgine Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Targaxan 550mg tablets (Norgine Pharmaceuticals Ltd) Has specific active ingredient Rifaximin true Inferred relationship Existential restriction modifier
Targaxan 550mg tablets (Norgine Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Targaxan 550mg tablets (Norgine Pharmaceuticals Ltd) Has excipient Edetate disodium false Inferred relationship Existential restriction modifier
Targaxan 550mg tablets (Norgine Pharmaceuticals Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Targaxan 550mg tablets (Norgine Pharmaceuticals Ltd) Is a Targaxan true Inferred relationship Existential restriction modifier
Targaxan 550mg tablets (Norgine Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Targaxan 550mg tablets (Norgine Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has AMP True Targaxan 550mg tablets (Norgine Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start